u/halima_boateng

Weekly dosing again, half-life in the same neighbourhood as sema, so a step change takes about a month to reach steady state.

certified_reference is right that the two molecules are not interchangeable. There is no published conversion and the ones circulating are invented.

I would not read a supply notice as a shortage in your pharmacy tomorrow. They are not the same thing.

no names without evidence, that is the sidebar rule and it is a good one

The directory deliberately separates "we have nothing on this name" from "this went badly". Collapsing the two is how boards like this generate false certainty.

Did you get the chromatogram or only the summary line?

Disagree on this specific point. Two honest labs can resolve that impurity differently and report different numbers.

My first certificate had a compound name, a percentage and a logo. I thought that was normal. It is not, and now I know what to ask for.

Not quite. Two labs with different gradients can resolve a close-eluting impurity differently and both be reporting honestly.

Asked a new shop for a batch-specific certificate before ordering.

aleksi_marchand has the group-buy risk right — it is structural, not a judgement about anybody in particular.

Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme. They are different endpoints and the numbers do not transfer.

The thing nobody warned me about was how much of this is logistics — storing it, remembering it, the same day every week.

Saving this one. It is the clearest statement of the stall problem I have read here.

The online consultation asked me three questions, none of them about my history. I did not go ahead.

Small fix — archiving happens at a year, not at six months. It is in the published policy.

That is the controversial ordering, not the hot one. Different formula, different behaviour.

group buys concentrate risk in one person and nobody plans for that

Cosigning on discharge at goal. It catches people who have done everything right and did not know it was coming.

How long have you been on the list, and from what date?

Small fix — that is the Scottish pathway. The post is asking about England and the answer is different.

Pushing back a little: a missing field is usually presentation, not concealment. Ask for the full document before drawing conclusions.

net peptide content and purity are two different numbers on the same vial

Ask what the stability statement was written against — temperature, light, and whether it was the lyophilised powder or the reconstituted solution. Those are three different claims.

GP said no in the spring, specialist said yes eighteen months later. Same person, same numbers.

this place sells nothing and takes nothing from any supplier

Nearly paid a cloned storefront. Caught it because one character in the domain was wrong and I paste rather than type.

GP said no in the spring, specialist said yes eighteen months later. Same person, same numbers.

Read the MHRA notice rather than the news coverage and the actual scope was much narrower than the panic threads suggested.

Correction to my own post above — I said 7.5mg and I have been on 5mg since the spring.

elin_varga is right that the two molecules are not interchangeable. There is no published conversion and the ones circulating are invented.

Not convinced — the US threads are a different system entirely and importing their advice here does real harm.

Net peptide content is the fraction of the powder that is actually peptide once counterion, water and residual solvent are accounted for. A 99% pure acetate salt can still be about 85% peptide by mass.

Net peptide content is the fraction of the powder that is actually peptide once counterion, water and residual solvent are accounted for. A 99% pure acetate salt can still be about 85% peptide by mass.

Agreed, and the trial number is a mean of a very wide distribution — the tails are enormous and nobody posts from the middle.

a shop that will only talk off-platform has told you something

Agreed, with one qualifier: that is the mean of the top arm and the spread around it was enormous.

Saving this one. It is the clearest statement of the stall problem I have read here.

Small fix — that is the Scottish pathway. The post is asking about England and the answer is different.

The distribution matters more than the mean. In the trial population the interquartile spread was wide enough that two honest people can have completely different runs on the same arm.

never accuse an individual, describe what happened to you

bianca_demir has the group-buy risk right — it is structural, not a judgement about anybody in particular.